An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, Gabrielle, Hellmann, Jason, Proto, Jonathan D., Kuriakose, George, Colas, Romain A., Dorweiler, Bernhard, Connolly, E. Sander, Solomon, Robert +4 more·2016·Nature Communications

DOI 10.1038/ncomms12859

Cited by (412)

Items 201–300 of 412

Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators
Agua Sobrino, Mary Ellen Walker, Romain Alexandre Colas, Jesmond Dalli · 2020 · PLoS ONE
Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
Darrell C. Andrews, Catherine Godson · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to Inflammation
Kim E. Dzobo, Katie Hanford, Jeffrey Kroon · 2021 · Immunometabolism
Lipid Droplets as Regulators of Metabolism and Immunity
Dominique M. Boucher, Viyashini Vijithakumar, Mireille I. Ouimet · 2021 · Immunometabolism
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
Juan José Salazar, Daniela Pírela, Manuel Nava, Ana Valéria Castro, Lissé Angarita, Heliana Parra, Samuel Durán‐Agüero, Diana Marcela Rojas-Gómez, Néstor Galbán, Roberto Áñez et al. · 2022 · International Journal of Molecular Sciences
Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages
Shigeyasu Tsuda, Masakazu Shinohara, Toshihiko Oshita, Manabu Nagao, Nobuaki K. Tanaka, Takeshige Mori, Tetsuya Hara, Yasuhiro Irino, Ryuji Toh, Tatsuro Ishida et al. · 2017 · Scientific Reports
Mechanism of Chronic Stress-induced Reduced Atherosclerotic Medial Area and Increased Plaque Instability in Rabbit Models of Chronic Stress
Zemou Yu, Xiaotao Deng, Ruomei Qi, Lu-Yan Xiao, Chongqing Yang, Tao Gong · 2018 · Chinese Medical Journal
Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
Jesmond Dalli, Esteban A. Gómez, Charlotte Camille Jouvene · 2022 · Biomolecules
Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease
Trinidad A. Mariqueo, Jessica Zúñiga‐Hernández · 2020 · Prostaglandins Leukotrienes and Essential Fatty Acids
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Ana María Briones, Raquel Hernanz, Ana B. García‐Redondo, Cristina Rodrı́guez, Luis Miguel Blanco‐Colio, Almudena Val‐Blasco, María Jesús Alonso, Mercedes Salaíces · 2025 · Basic & Clinical Pharmacology & Toxicology
Effect of dietary DHA/EPA ratio on the early development, antioxidant response and lipid metabolism in larvae of Siberia sturgeon (Acipenser baerii, Brandt)
Lin Luo, Lichuan Ai, Xiaofang Liang, Wei Xing, Huanhuan Yu, Yinhua Zheng, Xiufeng Wu, Xu‐Fang Liang, Min Xue · 2018 · Aquaculture Nutrition
Omega-3 Polyunsaturated Fatty Acid Intervention Against Established Autoimmunity in a Murine Model of Toxicant-Triggered Lupus
James J. Pestka, Peyman Akbari, Kathryn A. Wierenga, Melissa A. Bates, Kristen N. Gilley, James G. Wagner, Ryan P. Lewandowski, Lichchavi Dhananjaya Rajasinghe, Preeti Chauhan, A.L. Lock et al. · 2021 · Frontiers in Immunology
LncRNA H19 Mitigates Oxidized Low-Density Lipoprotein Induced Pyroptosis via Caspase-1 in Raw 264.7 Cells
Shan Liu, Dongsheng Xu, Jiulong Ma, Peng Huang, Di Wu, Li-qun Ren · 2021 · Inflammation
Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment
Xin Tang, Lan Liu, Zhijuan Miao, Jiawei Zhang, Xiaolong Cai, Bing–Qiao Zhao, Gefei Chen, Marianne Schultzberg, Yuwu Zhao, Xiuzhe Wang · 2022 · Free Radical Biology and Medicine
Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases
Mengmeng Zhao, Chenfei Li, Jishou Zhang, Zheng Yin, Zihui Zheng, Jun Wan, Menglong Wang · 2022 · Pharmacological Research
Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke
Jiheng Hao, Yao Feng, Xin Juan Xu, Long Li, Kun Yang, Gaolei Dai, Weiwei Gao, Meng Zhang, Yaming Fan, Tengkun Yin et al. · 2022 · Frontiers in Immunology
Enhanced silver nanoparticle-induced pulmonary inflammation in a metabolic syndrome mouse model and resolvin D1 treatment
Saeed Alqahtani, Li Xia, Jonathan H. Shannahan · 2022 · Particle and Fibre Toxicology
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Marisabel Mecca, Simona Picerno, Salvatore Cortellino · 2024 · International Journal of Molecular Sciences
Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Gabrielle Fredman · 2019 · Frontiers in Pharmacology
Soyasaponins A 1 and A 2 exert anti-atherosclerotic functionalities by decreasing hypercholesterolemia and inflammation in high fat diet (HFD)-fed ApoE −/− mice
Qunying Xie, Fei Xiong, Xinglong Wu, Junbin Chen, Xiangfu Gu, Chuhong Su, Lingyu Xiao, Zhongdaixi Zheng, Yuanhao Wei, Hidayat Ullah et al. · 2019 · Food & Function
Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring
Kathryn A. Wierenga, Rita S. Strakovsky, Abby D. Benninghoff, Lichchavi Dhananjaya Rajasinghe, A.L. Lock, Jack R. Harkema, James J. Pestka · 2020 · Frontiers in Immunology
Apoptotic cell-derived metabolites in efferocytosis-mediated resolution of inflammation
Yiwei Mao · 2021 · Cytokine & Growth Factor Reviews
Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
Roddy Hiram · 2022 · Molecular Biology Reports
The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy
Yunfei Yin, Mingyue Tan, Lianhua Han, Lei Zhang, Yue Zhang, Jun Zhang, Wanqian Pan, Jiaxiang Bai, Tingbo Jiang, Hongxia Li · 2023 · Acta Pharmaceutica Sinica B
Macrophage mediators and mechanisms in cardiovascular disease
Patrik Schelemei, Elena Wagner, Felix S.R. Picard, Holger Winkels · 2024 · The FASEB Journal
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation
Shabnam Radbakhsh, Niki Katsiki, Raul D. Santos, Dimitri P. Mikhailidis, Christos Socrates Mantzoros, Amirhossein Sahebkar · 2022 · Metabolism
Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
Masharh Lipscomb, Sean Walis, Michael Marinello, Hebe Agustina Mena, Katherine C. MacNamara, Matthew R. Spite, Gabrielle Fredman · 2024 · The FASEB Journal
Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
Laurent Yvan‐Charvet, Stoyan Ivanov · 2020 · Journal of Lipid and Atherosclerosis
Plasma Resolvin D2 to Leukotriene B 4 Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis
Zhijuan Miao, Xin Tang, Marianne Schultzberg, Yuwu Zhao, Xiuzhe Wang · 2021 · BioMed Research International
Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance
Xin Ouyang, Zhongyong Liu · 2024 · Frontiers in Immunology
Protective Potential of Maresins in Cardiovascular Diseases
Min Liu, Huixiang He, Lihong Chen · 2022 · Frontiers in Cardiovascular Medicine
Roles of specialized pro-resolving mediators and omega-3 polyunsaturated fatty acids in periodontal inflammation and impact on oral microbiota
Chun-Teh Lee, Gena DeVue Tribble · 2023 · Frontiers in Oral Health
From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis
Chilan Bou Ghosson Leite, Gergő Merkely, Julia F. Charles, Christian M. Lattermann · 2023 · Current Osteoporosis Reports
Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
Ivana D. Djuricic, Philip C. Calder · 2024 · Nutrients
Inhibition of 5-lipoxygenase alleviates graft-versus-host disease
Bárbara Maximino Rezende, Rayssa Maciel Athayde, William Antônio Gonçalves, Carolina Braga de Resende, Priscila T. T. Bernardes, Denise Perez, Lísia Esper, Alesandra Côrte Reis, Milene Alvarenga Rachid, Marina Gomes Miranda e Castor et al. · 2017 · The Journal of Experimental Medicine
Cholesterol crystals increase vascular permeability by inactivating SHP2 and disrupting adherens junctions
Arul Murugan Mani, Rima Chattopadhyay, Nikhlesh Kumar Singh, Gadiparthi N. Rao · 2018 · Free Radical Biology and Medicine
Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions
Kathryn A. Wierenga, Jack R. Harkema, James J. Pestka · 2019 · Toxicologic Pathology
Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study
Runzhen Chen, Jiannan Li, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Nan Li, Weida Liu, Chen Liu, Peng Zhou, Yi Chen et al. · 2022 · Pharmacological Research
NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes
Madigan M. Reid, Marie-Audrey Ines Kautzmann, Gethein Andrew, André Obenaus, Pranab K. Mukherjee, Larissa Khoutorova, Jeff X. Ji, Cássia Rodrigues Roque, Reinaldo B. Oriá, Bola F. Habeb et al. · 2023 · Cellular and Molecular Neurobiology
Resolving atherosclerosis and Alzheimer disease
Gabrielle Fredman · 2019 · Nature Reviews Cardiology
Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases
Yuanyuan Cheng, Jianhui Rong · 2019 · Expert Opinion on Therapeutic Targets
Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions
Hanna Ruhanen, P.A. Nidhina Haridas, Matti Jauhiainen, Vesa M. Olkkonen · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation
Konstantin Neukirch, Khaled Alsabil, Chau Phi Dinh, Rossella Bilancia, Martin Raasch, Alexia Ville, Ida Cerqua, Guillaume Viault, Dimitri Bréard, Simona Pace et al. · 2021 · Journal of Medicinal Chemistry
The Ins and Outs of Myeloid Cells in Atherosclerosis
Ariane Schumski, Carla Winter, Yvonne Döring, Oliver Soehnlein · 2018 · Journal of Innate Immunity
Omega-3 polyunsaturated fatty acids modify the inverse association between systemic inflammation and cardiovascular fitness
Gabrielle Farley, Daniel W. Riggs, Aruni Bhatnagar, Jason L. Hellmann · 2021 · Clinical Nutrition
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, Gerwyn, Berk, Michael, Walder, Ken, O’Neil, Adrienne, Maes, Michael, Puri, Basant K. · 2021 · Neuroscience & Biobehavioral Reviews
The carotid plaque as paradigmatic case of site-specific acceleration of aging process: The microRNAs and the inflammaging contribution
Salvatore Collura, Cristina Morsiani, Andrea Vacirca, Sara Fronterrè, Carmen Ciavarella, Francesco Vasuri, Antonietta D’Errico, Claudio Franceschi, Gianandrea Pasquinelli, Mauro Gargiulo et al. · 2020 · Ageing Research Reviews
Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential
Anna De Bartolo, Naomi Romeo, Tommaso Angelone, Carmine Rocca · 2025 · Acta Physiologica
Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication
Chaofu Li, Zimu Wang, Yukun Yang, Qiuyan Jiang, Yingying Jiang, Jun Xiao, Li Shen, Wei Wu, Chuanwei Li · 2026 · Molecular Biomedicine
Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
Pilar Irún, Patricia Carrera‐Lasfuentes, Marta Sánchez‐Luengo, Úrsula Belío, María José Domper-Arnal, Gustavo A. Higuera, Malena Hawkins, Xavier de la Rosa, Ángel Lanas · 2023 · International Journal of Molecular Sciences
The brain–gut axis, inflammatory bowel disease and bioelectronic medicine
Michael Eberhardson, Yaakov A. Levine, Laura Tarnawski, Peder S. Olofsson · 2021 · International Immunology
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins
Hanna Ruhanen, P.A. Nidhina Haridas, Ilenia Minicocci, J. Taskinen, Francesco Palmas, Alessia Di Costanzo, Laura D’Erasmo, Jari Metso, Jennimari Partanen, Jesmond Dalli et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) in patients with allergic rhinitis
Ramin Lotfi, Akram Davoodi, Seyed Hamidreza Mortazavi, Ali Gorgin Karaji, Hanieh Tarokhian, Alireza Rezaiemanesh, Farhad Salari · 2020 · Molecular Biology Reports
ADSA Foundation Scholar Award: Shakin' off the rust—Oxidative stress and redox status as underlying factors of immune dysfunction in periparturient cows and preweaning calves
Ángel Abuelo · 2025 · Journal of Dairy Science
Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
Subhapradha Rangarajan, Davit Orujyan, Patrida Rangchaikul, Mohamed M. Radwan · 2022 · Biomedicines
M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes
Wenpeng Zhao, Yingqi Xu, Jiabao Zhu, Chaoxuan Zhang, Weimin Zhou, Shizhi Wang · 2024 · Scientific Reports
Cardiac Resolvin D2 ameliorates sepsis-induced cardiomyopathy via inhibiting Caspase-11/GSDMD dependent pyroptosis
Wen-wu Zhang, Shun-shun Wang, Yang-dong Ding, Xinyi Wu, Ting Chen, Ye Gao, Shengwei Jin, Puhong Zhang · 2024 · Free Radical Biology and Medicine
Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer
Muhammad Usman Babar, Ala F. Nassar, Xinxin Nie, Tianxiang Zhang, Jianwei He, Jacky T. Yeung, Paul C. Norris, Hideki Ogura, Anne Muldoon, Lieping Chen et al. · 2024 · Metabolites
Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases
Mohan Satish, Devendra K. Agrawal · 2018 · Expert Review of Cardiovascular Therapy
Omega-3 Polyunsaturated Fatty Acids and the Resolution of Inflammation: Novel Therapeutic Opportunities for Aortic Valve Stenosis?
Gonzalo Artiach, Magnus Bäck · 2020 · Frontiers in Cell and Developmental Biology
Reduced Levels of Plasma Lipoxin A4 Are Associated with Post-Stroke Cognitive Impairment
Xiuzhe Wang, Zhijuan Miao, Xiaofeng Xu, Marianne Schultzberg, Yuwu Zhao · 2020 · Journal of Alzheimer s Disease
Prostaglandin E2, 9S-, 13S-HODE and resolvin D1 are strongly associated with the post-stroke cognitive impairment
Dariusz Kotlęga, Barbara Peda, Arleta Drozd, Agnieszka Zembroń-Łacny, Ewa Stachowska, J. Gramacki, Małgorzata Szczuko · 2021 · Prostaglandins & Other Lipid Mediators
<p>Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date</p>
Jia, Xiaoming, Koh, Stephanie, Al Rifai, Mahmoud, Blumenthal, Roger S, Virani, Salim S · 2020 · Vascular Health and Risk Management
Specialized Pro-Resolving Mediators Derived from N-3 Polyunsaturated Fatty Acids: Role in Metabolic Syndrome and Related Complications
Laurent Dubé, Schohraya Spahis, Karelle Lachaîne, Andreanne Lemieux, Hanine Monhem, Sarah-Maude Poulin, Carolane Randoll, Eva Travaillaud, Nour-El-Houda Ould-Chikh, Valérie Marcil et al. · 2022 · Antioxidants and Redox Signaling
Resolution Pharmacology: State-of-the-art and therapeutic landscape
Mauro Perretti, Trinidad Montero‐Melendez · 2025 · Pharmacological Reviews
Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases
Raphael Campos Guimarães, Tiago Tomazini Gonçalves, Luiz Osório Leiria · 2020 · British Journal of Pharmacology
Bioactive lipids and metabolic syndrome—a symposium report
Loren M. DeVito, Edward A. Dennis, Barbara B. Kahn, Gerald I. Shulman, Joseph Lee Witztum, Sudeshna Sadhu, Joseph T. Nickels, Matthew R. Spite, Susan S. Smyth, Sarah Spiegel · 2022 · Annals of the New York Academy of Sciences
DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2
Amel Bouhadoun, Hasanga D. Manikpurage, Catherine Deschildre, Sara Zalghout, Marc Dubourdeau, Valérie Urbach, Benoît Ho‐Tin‐Noé, Lydia Deschamps, Jean‐Baptiste Michel, Dan Longrois et al. · 2022 · Prostaglandins & Other Lipid Mediators
Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
Maria Anghelache, Geanina Voicu, Mariana Deleanu, Mihaela Turtoi, Florentina Safciuc, Ruxandra Anton, Delia Boteanu, Ioana Mădălina Fenyo, Ileana Mânduțeanu, Maya Simionescu et al. · 2023 · Advanced Healthcare Materials
Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression
Brian T. Steffen, Weihua Guan, James H. Stein, Mathew C. Tattersall, Joel D. Kaufman, Veit Sandfort, Moysés Szklo, Michael Y. Tsai · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise?
Phillip Chuong, Marcin Wysoczynski, Jason L. Hellmann · 2019 · Frontiers in Cardiovascular Medicine
TAM receptors and their ligand-mediated activation: Role in atherosclerosis
Bishuang Cai, Canan Kasikara · 2020 · International review of cytology
Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
Andrea Gila-Díaz, Gloria Herranz Carrillo, Pratibha Singh, David Ramiro‐Cortijo · 2021 · Antioxidants
Self‐Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche
Erica B. Peters, Mark R. Karver, Kui Sun, David C. Gillis, Suvendu Biswas, Tristan D. Clemons, Wenhan He, Nick D. Tsihlis, Samuel Isaac Stupp, Melina R. Kibbe · 2021 · Advanced Therapeutics
Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease
Matthew R. Spite, Gabrielle Fredman · 2023 · Advances in pharmacology
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew J. Butcko, Ashley K. Putman, Emilio P. Mottillo · 2024 · Antioxidants
Inflammatory Mechanisms in Atherosclerosis
Ida Gregersen, Bente Lise Halvorsen · 2018 · InTech eBooks
Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) may contribute to the pathogenesis of atherosclerosis
Mohsen Molaie, Ramin Lotfi, Reza Heidari Moghadam, Alireza Rezaiemanesh, Ali Gorgin Karaji, Farhad Salari · 2023 · Prostaglandins & Other Lipid Mediators
Pro-resolution therapeutics for cardiovascular diseases
Justin Heinz, Michael Marinello, Gabrielle Fredman · 2017 · Prostaglandins & Other Lipid Mediators
Sulfated polysaccharide from Undaria pinnatifida stabilizes the atherosclerotic plaque via enhancing the dominance of the stabilizing components
Zhuoyue Song, Hailun Li, Jian Liang, Yingtao Xu, Lijun Zhu, Xianying Ye, Jun Wu, Wěi Li, Qingping Xiong, Shijie Li · 2019 · International Journal of Biological Macromolecules
Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation
Jesmond Dalli, Kimberly Pistorius, Mary Ellen Walker · 2019 · Advances in experimental medicine and biology
Programming and memory dynamics of innate leukocytes during tissue homeostasis and inflammation
Christina Lee, Shuo Geng, Yao Zhang, Allison Rahtes, Liwu Li · 2017 · Journal of Leukocyte Biology
Specialized pro-resolving mediators in neutrophil apoptosis regulation: unlocking novel therapeutic potential in kidney diseases
Yi Kang, Qian Jin, Mengqi Zhou, Huijuan Zheng, D R Li, Xuezhe Wang, Jingwei Zhou, Yaoxian Wang, Jie Lv · 2025 · Frontiers in Immunology
Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis
Stanislav Nikolaevich Kotlyarov · 2024 · Current Medicinal Chemistry
MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of ischemia/reperfusion injury after lung transplant
Victoria Leroy, Denny Joseph Manual Kollareth, Zhenxiao Tu, Jeff Arni C. Valisno, Makena Woolet-Stockton, Biplab Kumar Saha, Amir M. Emtiazjoo, Mindaugas Rackauskas, Lyle L. Moldawer, Philip Alexander Efron et al. · 2024 · JCI Insight
“A Time to Tear Down and a Time to Mend”: The Role of Eicosanoids in Atherosclerosis
Samuel C. R. Sherratt, Richard Preston Mason, Peter Libby, Deepak L. Bhatt · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis
S. Kotlyarov · 2022 · Genes
Acute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio
Changqing Sun, Wuyang Zheng, Ling Liang, Ziguan Zhang, Zuheng Liu, Wenchao Sun, Jianwei Zhou, Weitong Qiao, Qiang Xie, Rong Tang · 2023 · International Heart Journal
Metabolic Regulators of Vascular Inflammation
Garrett Fairman, Sabrina Robichaud, Mireille I. Ouimet · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
Elizabeth G. Wood, Claire E. Macdougall, Hazel C. Blythe, Marc Clément, Romain Alexandre Colas, Jesmond Dalli, Federica M. Marelli‐Berg, Maria Paula Longhi · 2020 · Scientific Reports
Inflammation and its resolution in coronary artery disease: a tightrope walk between omega-6 and omega-3 polyunsaturated fatty acids
Gonzalo Artiach, Philip Sarajlic, Magnus Bäck · 2020 · Kardiologia Polska
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis
David Ngai, Santosh Reddy Sukka, Ira A. Tabas · 2024 · Frontiers in Immunology
Neural reflex control of vascular inflammation
April S. Caravaca, Monica Centa, Alessandro L. Gallina, Laura Tarnawski, Peder S. Olofsson · 2020 · Bioelectronic Medicine
Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway
Wei Cheng, Jishou Zhang, Shanshan Peng, Jianfang Liu, Yao Qun Xu, Mengmeng Zhao, Shuwan Xu, Wei Dong Pan, Zheng Yin, Zihui Zheng et al. · 2023 · Journal of Hypertension
Lipidomic profiling of virus infection identifies mediators that resolve herpes simplex virus-induced corneal inflammatory lesions
Cuiping Zhang, Zuojian Hu, Ke Wang, Lujie Yang, Yue Li, Hartmut Schlüter, Pengyuan Yang, Jiaxu Hong, Hongxiu Yu · 2020 · The Analyst
Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque
Edward Benjamin Thorp · 2016 · Circulation Research
Novel UV‐B Phototherapy With a Light‐Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T‐Cell Responses in Mice
Toru Tanaka, Naoto Sasaki, Aga Krisnanda, Masakazu Shinohara, Hilman Zulkifli Amin, Sayo Horibe, Ken Ito, Motoaki Iwaya, Atsushi Fukunaga, Ken‐ichi Hirata et al. · 2024 · Journal of the American Heart Association
Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases
Yu Deng, Fei Wang, Tianle Wang, Xu Zhang, Du Chen, Yuhan Wang, Chaojun Chen, Guangtao Pan · 2024 · Prostaglandins & Other Lipid Mediators
Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis
Qianru Zhou, Yujie Wang, Guangxiang Si, Xingbiao Chen, Dan Mu, Bing Zhang · 2025 · Chemical & Biomedical Imaging
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis
Lale Özcan, Canan Kasikara, Arif Yurdagul, George Kuriakose, Brian K. Hubbard, Michael H. Serrano‐Wu, Ira A. Tabas · 2021 · PLoS ONE